425 related articles for article (PubMed ID: 25983148)
1. Bioresorbable vascular scaffolds in left main coronary artery disease.
Everaert B; Capranzano P; Tamburino C; Seth A; van Geuns RJ
EuroIntervention; 2015; 11 Suppl V():V135-8. PubMed ID: 25983148
[TBL] [Abstract][Full Text] [Related]
2. Bioresorbable vascular scaffolds for the treatment of coronary artery disease: Clinical outcomes from randomized controlled trials.
Rizik DG; Hermiller JB; Kereiakes DJ
Catheter Cardiovasc Interv; 2016 Nov; 88(S1):21-30. PubMed ID: 27797464
[TBL] [Abstract][Full Text] [Related]
3. Paving the way to a bioresorbable technology: Development of the absorb BRS program.
Perkins LE; Kossuth MB; Fox JC; Rapoza RJ
Catheter Cardiovasc Interv; 2016 Nov; 88(S1):1-9. PubMed ID: 27797462
[TBL] [Abstract][Full Text] [Related]
4. Design Principles of Bioresorbable Polymeric Scaffolds.
Kossuth MB; Perkins LEL; Rapoza RJ
Interv Cardiol Clin; 2016 Jul; 5(3):349-355. PubMed ID: 28582032
[TBL] [Abstract][Full Text] [Related]
5. Impact of overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST-EU registry.
Ortega-Paz L; Capodanno D; Giacchi G; Gori T; Nef H; Latib A; Caramanno G; Di Mario C; Naber C; Lesiak M; Capranzano P; Wiebe J; Mehilli J; Araszkiewicz A; Pyxaras S; Mattesini A; Geraci S; Naganuma T; Colombo A; Münzel T; Sabaté M; Tamburino C; Brugaletta S
Catheter Cardiovasc Interv; 2017 Apr; 89(5):812-818. PubMed ID: 27515568
[TBL] [Abstract][Full Text] [Related]
6. The unmet needs: How future technologies will address current limitations of bioresorbable scaffold technology.
Abizaid A; Ribamar Costa J
Catheter Cardiovasc Interv; 2016 Nov; 88(S1):54-59. PubMed ID: 27797459
[TBL] [Abstract][Full Text] [Related]
7. What about the risk of thrombosis with bioresorbable scaffolds?
Capodanno D; Joner M; Zimarino M
EuroIntervention; 2015; 11 Suppl V():V181-4. PubMed ID: 25983162
[TBL] [Abstract][Full Text] [Related]
8. No more metallic cages: an attractive hybrid strategy with bioresorbable vascular scaffold and drug-eluting balloon for diffuse or tandem lesions in the same vessel.
Naganuma T; Latib A; Ielasi A; Panoulas VF; Sato K; Miyazaki T; Colombo A
Int J Cardiol; 2014 Apr; 172(3):618-9. PubMed ID: 24495653
[No Abstract] [Full Text] [Related]
9. Current and future perspectives on drug-eluting bioresorbable coronary scaffolds.
Ielasi A; Tespili M
Future Cardiol; 2014 May; 10(3):409-20. PubMed ID: 24976477
[TBL] [Abstract][Full Text] [Related]
10. Bioresorbable vascular scaffolds for left main lesions; a novel strategy to overcome limitations.
Miyazaki T; Panoulas VF; Sato K; Naganuma T; Latib A; Colombo A
Int J Cardiol; 2014 Jul; 175(1):e11-3. PubMed ID: 24845788
[No Abstract] [Full Text] [Related]
11. Bioresorbable vascular scaffolds: From patient selection to optimal scaffold implantation; tips and tricks to minimize device failure.
Tanaka A; Jabbour RJ; Latib A; Colombo A
Catheter Cardiovasc Interv; 2016 Nov; 88(S1):10-20. PubMed ID: 27797460
[TBL] [Abstract][Full Text] [Related]
12. Bioresorbable Scaffolds: Clinical Outcomes and Considerations.
Capodanno D
Interv Cardiol Clin; 2016 Jul; 5(3):357-363. PubMed ID: 28582033
[TBL] [Abstract][Full Text] [Related]
13. Bioresorbable scaffolds in daily clinical routine: a practical review of all-comers results.
Wiebe J; Hamm CW; Nef HM
Curr Opin Cardiol; 2015 Nov; 30(6):650-6. PubMed ID: 26447503
[TBL] [Abstract][Full Text] [Related]
14. Bioresorbable metal scaffold for cardiovascular application: current knowledge and future perspectives.
Kitabata H; Waksman R; Warnack B
Cardiovasc Revasc Med; 2014 Mar; 15(2):109-16. PubMed ID: 24684760
[TBL] [Abstract][Full Text] [Related]
15. Imaging and functional assessment of bioresorbable scaffolds.
Pighi M; Tanguay JF; L'allier PL
Minerva Cardioangiol; 2016 Aug; 64(4):442-61. PubMed ID: 27195663
[TBL] [Abstract][Full Text] [Related]
16. Current perspectives on the role of bioresorbable scaffolds in the management of coronary artery disease.
Dziewierz A; Dudek D
Kardiol Pol; 2018; 76(7):1043-1054. PubMed ID: 30251247
[TBL] [Abstract][Full Text] [Related]
17. When and how to use BRS in bifurcations?
Stankovic G; Lassen JF
EuroIntervention; 2015; 11 Suppl V():V185-7. PubMed ID: 25983163
[TBL] [Abstract][Full Text] [Related]
18. In vitro mechanical behavior and in vivo healing response of a novel thin-strut ultrahigh molecular weight poly-l-lactic acid sirolimus-eluting bioresorbable coronary scaffold in normal swine.
Cheng Y; Gasior P; Ramzipoor K; Lee C; McGregor JC; Conditt GB; McAndrew T; Kaluza GL; Granada JF
Int J Cardiol; 2019 Jul; 286():21-28. PubMed ID: 30967275
[TBL] [Abstract][Full Text] [Related]
19. Expansion in calcific lesions and overall clinical outcomes following bioresorbable scaffold implantation optimized with intravascular ultrasound.
Kawamoto H; Ruparelia N; Latib A; Miyazaki T; Sato K; Tanaka A; Naganuma T; Sticchi A; Chieffo A; Carlino M; Montorfano M; Colombo A
Catheter Cardiovasc Interv; 2017 Apr; 89(5):789-797. PubMed ID: 27545845
[TBL] [Abstract][Full Text] [Related]
20. Dislodgement of a magnesium bioresorbable scaffold from the delivery system in the left main: A true "nightmaris".
Cortés C; Jaguszewski M; Schincariol M; Durán-Cortés MA; Limon U; Gutiérrez-Chico JL
Cardiol J; 2017; 24(6):700-701. PubMed ID: 29297580
[No Abstract] [Full Text] [Related]
[Next] [New Search]
